MediWound Completes Enrollment Stage of its NexoBrid Phase 3 Pediatric Study

NEXT STORY
G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020
PREV STORY
Teleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Abpro Announces Positive Phase 1 Results Demonstrating A Favorable Safety and Pharmacokinetic Profile of ABP 300, A Neutralizing Antibody Therapeutic for the Treatment of COVID-19

author_avatar
NASDAQ Market News

ImCheck Achieves Initial Positive Independent Safety Review and Initiates Next Stage of Phase I/IIa EVICTION Trial for ICT01

author_avatar
NASDAQ Market News

ABT TEAM TO RESEARCH PAIN MANAGEMENT AND TREATMENT OF OPIOID USE DISORDER FOR ADOLESCENTS

author_avatar
NASDAQ Market News